Ioannis Matsoukas was born and raised in Patras. He studied in the Chemistry Department of the University of Patras in the first row of its students newly established University and subsequently at the University of New Brunswick in Canada where he obtained a Master’s degree M.Sc. in the organic synthesis of natural products. The doctoral thesis followed on the Chemistry Department of the University Patras in synthesis and spectroscopy study of peptides and amino acid derivatives. He performed post-doctoral research in the Department of Pharmacology of the School of Medicine University of Calgary in Canada (1981-1984) in the Renin angiotensin receptor (RAS), in the development of a new generation of antihypertensive products, Sartans, and their mechanism of action. He was elected and became an assistant and then a substitute and regular professor. In 2005 he was elected President of the Department of Chemistry promoting the excellence. He was the founder and for many years was the Director of the flagship interdepartmental postgraduate program ”Medicine Chemistry“ of the first in Greece awarded as Euromaster. He globalized the research of this program and invited to the annual Medicinal Chemistry conferences of world-renowned researchers among including six Nobel laureates. His research interests focus in the study of important peptides and hormones such as Angiotensine, Myelin epitopes and the Gonadotropic hormone that implicates respectively in Hypertension (the RAS system is associated with the disease Covid 19), Multiple Sclerosis, infertility and cancer. His research group was the first in the international literature that synthesized and studied cyclic peptides, synthetic masterpieces structures, to investigate the mechanism of action of angiotensin, myelin and gonadotropin. Big investments have been made for its exploitation of his research and has been honored with many awards. He has been awarded the title of Honorary Professor from the University of Calgary, Canada and Victoria, Australia with which it has a long and successful collaboration. He is in charge of international pharmaceutical research network and has a large number of publications in high- profile journals and many patent techniques. He is among the first scholar who ventured early to establish in Canada and Greece startup companies for the utilization of his research. Thomas Mavromoustakos was born in the suburb of Morfou in Cyprus in 1960. He studied in the Department of Chemistry of the National and Kapodistrian University of Athens (NKUA) from 1980-1985. He completed his postgraduate, doctoral and post-doctroal studies at the Department of Pharmacy of Connecticut of the United States of America from 1985-1990. From 1991-2007 he was working as a researcher at National Institute of Research. From 2012 he serves as a full professor at the Department of Chemistry of NKUA and in 2020 as Director of the Laboratory of Organic Chemistry. In 2022 he was elected as Vice-President of the Department of Chemistry of NKUA, at which he serves. As a researcher of the Department of Chemistry he studies the interactions of pharmaceutical products with receptors and lipidic bilayers, as well as with the transfer using delivery vehicles at the desired organs-targets. To achieve those goals he uses Nuclear Magnetic Resonance Solid State, X-ray Diffraction of small and large angle, Differential Scanning Calorimetry, Raman Spectroscopy and more. He also studies the interactions, with the active sites using Molecular Docking and Molecular Dynamics. He applies three-dimensional relations of structure and activity and data mining from data bases for the discovery of new molecules against neuro- degenerative and cardiovascular diseases. He is a Graduate of the Theological School (2007) and a doctor of Social Theology (2012). At Theology his research targets are the understanding of potential combinations of numbers and hours at the texts of the New Testament, which promote their interpretation and deeper understanding.